ANI Pharmaceuticals Inc banner

ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 80.34 USD -1.83%
Market Cap: $1.8B

Wall Street
Price Targets

ANIP Price Targets Summary
ANI Pharmaceuticals Inc

Wall Street analysts forecast ANIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIP is 111.91 USD with a low forecast of 90.9 USD and a high forecast of 130.2 USD.

Lowest
Price Target
90.9 USD
13% Upside
Average
Price Target
111.91 USD
39% Upside
Highest
Price Target
130.2 USD
62% Upside
ANI Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

76% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
76% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 4 years is 16%.

Operating Income
Forecast

N/A
Past Growth
167% / Year
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
167% / Year
Estimated Growth
Estimates Accuracy
-62%
Average Miss

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 4 years is 167%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIP's stock price target?
Price Target
111.91 USD

According to Wall Street analysts, the average 1-year price target for ANIP is 111.91 USD with a low forecast of 90.9 USD and a high forecast of 130.2 USD.

What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 76%. The projected CAGR for the next 4 years is 16%.

What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
167%

The compound annual growth rate of ANI Pharmaceuticals Inc's operating income for the next 4 years is 167%.

Back to Top